Corrected Oventus Presentation at Thorney Investment Forum
Corrected Oventus Presentation at Thorney Investment Forum
Brisbane, May 31, 2018 AEST (ABN Newswire) - Oventus Medical Ltd (ASX:OVN) is pleased to attach a copy of the presentation that Founder and Clinical Director, Dr Chris Hart will deliver to investors this morning at the Thorney Sydney Investment Forum.

Further information can be found on our website:

To view the presentation, please visit:

About Oventus Medical Ltd

Oventus Medical Ltd (ASX:OVN) is a Brisbane, Australia, based medical device company that is commercialising a new 'Sleep Treatment Platform' for the treatment of sleep apnoea and snoring. The Oventus platform enhances the treatment outcomes of both standard mouthguard-type oral appliance therapy (often used to treat mild to moderate sleep apnoea) and of Continuous Positive Airway Pressure (CPAP) therapy (often used to treat moderate to severe patients.)

Since the Oventus 'Sleep Treatment Platform' is generally well tolerated by patients, and incorporates a unique airway, which supports better breathing, it has been shown in clinical trials to have increased efficacy and provide greater adherence over the competing treatment options.

For more information on Oventus' Sleep Treatment Platform, please visit



Mr Neil Anderson
Managing Director and CEO
M: 0403 003 475

Jane Lowe
IR Department
M: 0411 117 774

Related Companies

Oventus Medical Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 70) (Last 30 Days: 364) (Since Published: 2660) 

Oventus Medical Ltd NEWS: RECENT VISITS (4843)